Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.25
+0.30 (4.39%)
At close: Jun 26, 2026, 4:00 PM EDT
7.25
+0.01 (0.09%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Kyntra Bio Employees
Kyntra Bio had 34 employees as of December 31, 2025. The number of employees decreased by 191 or -84.89% compared to the previous year.
Employees
34
Change (1Y)
-191
Growth (1Y)
-84.89%
Revenue / Employee
$218,794
Profits / Employee
$4,812,206
Market Cap
29.31M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Barinthus Biotherapeutics | 14 |
| NanoViricides | 7 |
KYNB News
- 15 days ago - Kyntra Bio Transcript: AGM 2026 - Transcripts
- 16 days ago - Kyntra Bio to present additional MATTERHORN trial data at EHA - TheFly
- 16 days ago - Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes - GlobeNewsWire
- 18 days ago - Kyntra Bio initiated with a Buy at Rodman & Renshaw - TheFly
- 6 weeks ago - Kyntra Bio Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Kyntra Bio Earnings release: Q1 2026 - Filings
- 6 weeks ago - Kyntra Bio Slides: Q1 2026 - Filings
- 6 weeks ago - Kyntra Bio Quarterly report: Q1 2026 - Filings